BYSI
BYSI
NASDAQ · Biotechnology

Beyondspring Inc

$1.73
+0.09 (+5.49%)
As of Apr 1, 3:26 PM ET ·
Financial Highlights (FY 2025)
Revenue
5.74M
Net Income
1.11M
Gross Margin
56.1%
Profit Margin
19.3%
Rev Growth
+19.1%
D/E Ratio
1.60
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 56.1% 56.1% 56.1%
Operating Margin 25.7% 28.1% 28.3%
Profit Margin 19.3% 22.9% 18.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 5.74M 5.58M 6.05M
Gross Profit 3.22M 3.13M 3.39M
Operating Income 1.47M 1.57M 1.71M
Net Income 1.11M 1.28M 1.11M
Gross Margin 56.1% 56.1% 56.1%
Operating Margin 25.7% 28.1% 28.3%
Profit Margin 19.3% 22.9% 18.3%
Rev Growth +19.1% +13.5% +5.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 28.49M 31.27M 29.42M
Total Equity 17.84M 18.75M 18.16M
D/E Ratio 1.60 1.67 1.62
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 2.54M 2.28M 2.52M
Free Cash Flow 874.9K 1.03M 1.03M